On February 6, 2024, the company announced an increase in its equity buyback plan. The company increased its authorization by $50 million, thereby bringing total authorization to $100 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.77 CNY | -1.67% | -3.29% | -5.54% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.54% | 381M | |
+15.09% | 74.45B | |
+11.41% | 9.18B | |
+54.35% | 5.03B | |
-12.85% | 5.02B | |
+1.60% | 3.82B | |
-20.85% | 2.41B | |
+16.88% | 2.39B | |
-29.25% | 2.27B | |
+24.62% | 2.26B |
- Stock Market
- Equities
- 002873 Stock
- News Guiyang Xintian Pharmaceutical Co.,Ltd.
- Guiyang Xintian Pharmaceutical Co.,Ltd. announces an Increase in Equity Buyback.